« Back to Record
Praga, C., Bergh, J., Bliss, J. M., Bonneterre, J., Cesana, B., Coombes, R. C., Fargeot, P., Folin, A., Fumoleau, P., Giuliani, R., Kerbrat, P., Hery, M., Nilsson, J., Onida, F., Piccart-Gebhart, M., Shepherd, L., Therasse, P., Wils, J., & Rogers, D. (2005). Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide. Journal of clinical oncology, 23(18), 4179-4191. doi:10.1200/JCO.2005.05.029
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55389



